BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23344789)

  • 21. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?
    Forsyth PA; Kelly PJ; Cascino TL; Scheithauer BW; Shaw EG; Dinapoli RP; Atkinson EJ
    J Neurosurg; 1995 Mar; 82(3):436-44. PubMed ID: 7861222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide.
    Yaman E; Buyukberber S; Benekli M; Oner Y; Coskun U; Akmansu M; Ozturk B; Kaya AO; Uncu D; Yildiz R
    Clin Neurol Neurosurg; 2010 Oct; 112(8):662-7. PubMed ID: 20627551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.
    Kumar AJ; Leeds NE; Fuller GN; Van Tassel P; Maor MH; Sawaya RE; Levin VA
    Radiology; 2000 Nov; 217(2):377-84. PubMed ID: 11058631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion-weighted MR imaging for the differentiation of true progression from pseudoprogression following concomitant radiotherapy with temozolomide in patients with newly diagnosed high-grade gliomas.
    Lee WJ; Choi SH; Park CK; Yi KS; Kim TM; Lee SH; Kim JH; Sohn CH; Park SH; Kim IH
    Acad Radiol; 2012 Nov; 19(11):1353-61. PubMed ID: 22884399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases.
    Preul MC; Leblanc R; Caramanos Z; Kasrai R; Narayanan S; Arnold DL
    Can J Neurol Sci; 1998 Feb; 25(1):13-22. PubMed ID: 9532276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic accuracy of diffusion MRI with quantitative ADC measurements in differentiating glioma recurrence from radiation necrosis.
    Zhang H; Ma L; Shu C; Wang YB; Dong LQ
    J Neurol Sci; 2015 Apr; 351(1-2):65-71. PubMed ID: 25748965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and treatment options for sequelae following radiation treatment of brain tumors.
    Mehta S; Shah A; Jung H
    Clin Neurol Neurosurg; 2017 Dec; 163():1-8. PubMed ID: 29028584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-treatment imaging changes in primary brain tumors.
    O'Brien BJ; Colen RR
    Curr Oncol Rep; 2014; 16(8):397. PubMed ID: 24997979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.
    Hatzoglou V; Yang TJ; Omuro A; Gavrilovic I; Ulaner G; Rubel J; Schneider T; Woo KM; Zhang Z; Peck KK; Beal K; Young RJ
    Neuro Oncol; 2016 Jun; 18(6):873-80. PubMed ID: 26688076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular imaging based on differential protein content in differentiating glioma from radiation necrosis.
    Jandial R; Duenas VJ; Chen BT
    Neurosurgery; 2011 Jun; 68(6):N16-7. PubMed ID: 21778943
    [No Abstract]   [Full Text] [Related]  

  • 31. Diagnostic Accuracy of Centrally Restricted Diffusion in the Differentiation of Treatment-Related Necrosis from Tumor Recurrence in High-Grade Gliomas.
    Zakhari N; Taccone MS; Torres C; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Nguyen TB
    AJNR Am J Neuroradiol; 2018 Feb; 39(2):260-264. PubMed ID: 29217742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
    Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
    Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery.
    Stockham AL; Tievsky AL; Koyfman SA; Reddy CA; Suh JH; Vogelbaum MA; Barnett GH; Chao ST
    J Neurooncol; 2012 Aug; 109(1):149-58. PubMed ID: 22638727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accurate differentiation of recurrent gliomas from radiation injury by kinetic analysis of α-11C-methyl-L-tryptophan PET.
    Alkonyi B; Barger GR; Mittal S; Muzik O; Chugani DC; Bahl G; Robinette NL; Kupsky WJ; Chakraborty PK; Juhász C
    J Nucl Med; 2012 Jul; 53(7):1058-64. PubMed ID: 22653792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
    Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI patterns of T1 enhancing radiation necrosis versus tumour recurrence in high-grade gliomas.
    Reddy K; Westerly D; Chen C
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):349-55. PubMed ID: 23721146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral Radiation Necrosis: Incidence, Pathogenesis, Diagnostic Challenges, and Future Opportunities.
    Ali FS; Arevalo O; Zorofchian S; Patrizz A; Riascos R; Tandon N; Blanco A; Ballester LY; Esquenazi Y
    Curr Oncol Rep; 2019 Jun; 21(8):66. PubMed ID: 31218455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Performance of PET and Perfusion-Weighted Imaging in Differentiating Tumor Recurrence or Progression from Radiation Necrosis in Posttreatment Gliomas: A Review of Literature.
    Soni N; Ora M; Mohindra N; Menda Y; Bathla G
    AJNR Am J Neuroradiol; 2020 Sep; 41(9):1550-1557. PubMed ID: 32855194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis.
    Sonoda Y; Kumabe T; Takahashi T; Shirane R; Yoshimoto T
    Neurol Med Chir (Tokyo); 1998 Jun; 38(6):342-7; discussion 347-8. PubMed ID: 9689817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of incidental low-grade gliomas using magnetic resonance imaging: systematic review and optimal treatment paradigm.
    Shah AH; Madhavan K; Heros D; Raper DM; Iorgulescu JB; Lally BE; Komotar RJ
    Neurosurg Focus; 2011 Dec; 31(6):E12. PubMed ID: 22133169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.